Improving clinical trial transparency at UK universities: Evaluating 3 years of policies and reporting performance on the European Clinical Trial Register

BACKGROUND: January 2019, the House of Commons’ Science and Technology Committee sent letters to UK universities admonishing them to achieve compliance with results reporting requirements for Clinical Trials of Investigative Medicinal Products by summer 2019. This study documents changes in the clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirjam Keestra, Sarai, Rodgers, Florence, Gepp, Sophie, Grabitz, Peter, Bruckner, Till
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036155/
https://www.ncbi.nlm.nih.gov/pubmed/35168372
http://dx.doi.org/10.1177/17407745211071015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036155/
https://www.ncbi.nlm.nih.gov/pubmed/35168372
http://dx.doi.org/10.1177/17407745211071015

Ejemplares similares